Abstract:Key PointsThe molecular mechanism of activation for a representative effector caspase, caspase-7, is revealed by the conformational changes of the active site that take place after the activation cleavage. The essence of this mechanism is the provision of the L2′ loop, which is released by the activation cleavage and provides crucial support for the conformation of the active site.The molecular mechanism of inhibitor of apoptosis (IAP)-mediated inhibition of an effector caspase primarily involves the occupation of the caspase active site by an extended peptide fragment that immediately precedes the second baculoviral IAP repeat (BIR) domain, BIR2, of XIAP, c-IAP1 or c-IAP2.The BIR3 domain of XIAP inhibits caspase-9, an initiator caspase, by sequestering caspase-9 in a monomeric state, so that the L2′ loop cannot be provided by the adjacent monomer and the active site cannot be productively formed. This inhibition is dependent on, and initiated by, the binding between a conserved surface groove of the BIR3 domain of XIAP and the N-terminal tetrapeptide (Ala-Thr-Pro-Phe) of the small subunit of caspase-9.The viral protein p35 inhibits a caspase through the formation of a covalent thioester bond between the catalytic residue Cys360 of caspase-8 and Asp87 of p35, which follows caspase-mediated cleavage of the reactive-site loop of p35 after Asp87.The XIAP-mediated inhibition of caspase-9 can be countered effectively by SMAC/DIABLO, which uses its N-terminal tetrapeptide (Ala-Val-Pro-Ile) to compete with caspase-9 for binding to the same conserved surface groove of the BIR3 domain of XIAP. In Drosophila melanogaster, the caspase-9 orthologue Dronc is suppressed by Diap1 through an interaction that involves an internal peptide fragment of Dronc and the conserved surface groove of the BIR2 domain of Diap1. The pro-apoptotic proteins Reaper, Hid, Grim and Sickle use their N-terminal peptide fragments (which are similar to the SMAC/DIABLO tetrapeptide) to compete with Dronc for binding to the same conserved surface groove, thereby removing the Diap1-mediated negative regulation of Dronc.The exact mechanisms for the removal of effector-caspase inhibition remain to be defined. The prevailing model, which is supported by biochemical data, is that the binding of effector caspases by SMAC/DIABLO creates steric hindrance that dissociates the interaction between IAPs and the effector caspases.To gain a comprehensive picture of the molecular mechanisms of caspase regulation, future efforts should be directed at understanding the activation of initiator caspases and caspase pathways in Drosophila melanogaster and Caenorhabditis elegans.

Molecular Basis of Caspase-1 Polymerization and Its Inhibition by a New Capping Mechanism

Crystal structure of caspase-11 CARD provides insights into caspase-11 activation

Novel mode of filament formation in UPA-promoted CARD8 and NLRP1 Inflammasomes

Inhibiting the inflammasome: one domain at a time

Fused Bicyclic Caspase‐1 Inhibitors Assembled by Copper‐Free Strain‐Promoted Alkyne–Azide Cycloaddition (SPAAC)

Discovery of a Covalent Inhibitor of Pro-Caspase-1 Zymogen Blocking NLRP3 Inflammasome Activation and Pyroptosis

The tetrapeptide sequence of IL-1β regulates its recruitment and activation by inflammatory caspases

Single-cell imaging of inflammatory caspase dimerization reveals differential recruitment to inflammasomes

Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes

Cryopyrin and pyrin activate caspase-1, but not NF-κB, via ASC oligomerization

Molecular Determinants of Caspase-9 Activation by the Apaf-1 Apoptosome

Molecular mechanism of pyroptosis and inflammasome activation

Caspase-4 dimerisation and D289 auto-processing elicit an interleukin-1{beta}-converting enzyme

Mechanism of XIAP-Mediated Inhibition of Caspase-9

Discovery of a caspase cleavage motif antibody reveals insights into noncanonical inflammasome function

Catalytic activity and autoprocessing of murine caspase-11 mediate noncanonical inflammasome assembly in response to cytosolic LPS

ASC oligomer favors caspase-1CARD domain recruitment after intracellular potassium efflux

Molecular mechanisms of caspase regulation during apoptosis

Inhibitory Mechanism of Caspase-6 Phosphorylation Revealed by Crystal Structures, Molecular Dynamics Simulations, and Biochemical Assays*

Structural, Computational, Docking and Biological Studies of a Triaminopyrimidine Caspase-1 Inhibitor

Structural transitions enable interleukin-18 maturation and signaling